Clementina Castro-Hernández Unidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología-Instituto de Investigaciones Biomédicas Universidad Nacional Autónoma de México Biography Publications Institution JoVE Articles Clementina Castro-Hernández has not added a biography. If you are Clementina Castro-Hernández and would like to personalize this page please email our Author Liaison for assistance. Publications Effect of Inulin Intervention on Metabolic Control and Methylation of and Genes in Patients with Type 2 Diabetes Mellitus Nutrients. Dec, 2022 | Pubmed ID: 36501225 Transcriptomics and RNA-Based Therapeutics As Potential Approaches to Manage SARS-CoV-2 Infection International Journal of Molecular Sciences. Sep, 2022 | Pubmed ID: 36232363 Methylation of Subtelomeric Chromatin Modifies the Expression of the LncRNA TERRA, Disturbing Telomere Homeostasis International Journal of Molecular Sciences. Mar, 2022 | Pubmed ID: 35328692 Association of Polymorphisms in Estrogen Receptor Genes (1 and 2) with Osteoporosis and Fracture-Involvement of Comorbidities and Epistasis DNA and Cell Biology. Apr, 2022 | Pubmed ID: 35285722 Large-scale Topological Disruption of Chromosome Territories 9 and 22 is Associated with Nonresponse to Treatment in CML International Journal of Cancer. May, 2022 | Pubmed ID: 34913480 Genotoxicity of Marijuana in Mono-Users Frontiers in Psychiatry. 2021 | Pubmed ID: 34938210 Transcriptome Analysis Identifies GATA3-AS1 As a Long Noncoding RNA Associated with Resistance to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients The Journal of Molecular Diagnostics : JMD. Oct, 2021 | Pubmed ID: 34358678 Landscape of Germline Genetic Variants in AGT, MGMT, and TP53 in Mexican Adult Patients with Astrocytoma Cellular and Molecular Neurobiology. Aug, 2021 | Pubmed ID: 32535722 Prognostic Significance of the MAD1L1 1673 G: A Polymorphism in Ovarian Adenocarcinomas Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion. Dec, 2020 | Pubmed ID: 33052898 Prognostic Significance of the MAD1L1 1673 G: A Polymorphism in Ovarian Adenocarcinomas Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion. May, 2020 | Pubmed ID: 32488223 Association of the Promoter Methylation and the Rs12917 Polymorphism of MGMT with Formation of DNA Bulky Adducts and the Risk of Lung Cancer in Mexican Mestizo Population DNA and Cell Biology. Apr, 2019 | Pubmed ID: 30785779 Angiotensinogen Rs5050 Germline Genetic Variant As Potential Biomarker of Poor Prognosis in Astrocytoma PloS One. 2018 | Pubmed ID: 30383794 CTCF-KDM4A Complex Correlates with Histone Modifications That Negatively Regulate Gene Expression in Cancer Cell Lines Oncotarget. Mar, 2018 | Pubmed ID: 29682202 MAD2γ, a Novel MAD2 Isoform, Reduces Mitotic Arrest and is Associated with Resistance in Testicular Germ Cell Tumors Cell Cycle (Georgetown, Tex.). Aug, 2016 | Pubmed ID: 27315568 Polymorphisms Associated with the Risk of Lung Cancer in a Healthy Mexican Mestizo Population: Application of the Additive Model for Cancer Genetics and Molecular Biology. Oct, 2011 | Pubmed ID: 22215955 Polymorphism of CYP1A1*2C, GSTM1*0, and GSTT1*0 in a Mexican Mestizo Population: a Similitude Analysis Human Biology. Aug, 2008 | Pubmed ID: 19317600 Antisense Oligonucleotides as a Tool for Prolonged Knockdown of Nuclear lncRNAs in Human Cell Lines Rogelio Montiel-Manriquez1, Clementina Castro-Hernández1, Cristian Arriaga-Canon1, Luis A. Herrera1,2 1Unidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología-Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, 2Escuela de Medicina y Ciencias de la Salud, Tecnológico de Monterrey JoVE 65124 癌症研究
Antisense Oligonucleotides as a Tool for Prolonged Knockdown of Nuclear lncRNAs in Human Cell Lines Rogelio Montiel-Manriquez1, Clementina Castro-Hernández1, Cristian Arriaga-Canon1, Luis A. Herrera1,2 1Unidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología-Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, 2Escuela de Medicina y Ciencias de la Salud, Tecnológico de Monterrey JoVE 65124 癌症研究